Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer halts studies on osteoarthritis drug
Yahoo/AP
Thursday, June 24, 2010 - 8:42am
tags:
Pfizer, osteoarthritis, tanezumab
Sanofi-Aventis Is `on Track' to Meet Diabetes Sales Targets, Chancel Says
Bloomberg
Thursday, June 24, 2010 - 8:41am
tags:
Sanofi, diabetes, Lantus, Victoza, Novo Nordisk
Drugmakers Finally Recognize the Next Big Opportunity
Motley Fool
Thursday, June 24, 2010 - 8:38am
tags:
BioSante, Merck, GSK, Abbott Laboratories, Neurocrine, Teva Pharmaceuticals, women
Targacept, AstraZeneca begin Phase 3 trial of antidepressant
Bizjournals.com
Wednesday, June 23, 2010 - 11:01am
tags:
Targacept, AstraZeneca, clinical trials, antidepressants
Cubist Pharmaceuticals vs. the Hatch-Waxman Act
Seeking Alpha
Wednesday, June 23, 2010 - 10:59am
tags:
Cubist Pharmaceuticals, Cubicin
Sucampo Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Wednesday, June 23, 2010 - 10:58am
tags:
Sucampo
Buy Vivus Bullish Options Before Review of Obesity Drug, JPMorgan Advises
Bloomberg
Wednesday, June 23, 2010 - 10:57am
tags:
Vivus, obesity
Biotech Stocks Losing Strength
Minyanville
Wednesday, June 23, 2010 - 10:56am
tags:
biotech, Amgen, Gilead Sciences, Biogen Idec, Merck, Eli Lilly, Pfizer, GSK
Genentech says Lucentis gets new FDA approval
Yahoo/AP
Wednesday, June 23, 2010 - 9:14am
tags:
FDA, Genentech, Lucentis, macular edema
Aetna Confirms It Will Cover Provenge
Minyanville
Wednesday, June 23, 2010 - 9:13am
tags:
Aetna, Provenge, prostate cancer, Dendreon
Glaxo Settles Nearly 200 Paxil Birth Defect Lawsuits
Pharmalot
Wednesday, June 23, 2010 - 9:08am
tags:
Paxil, antidepressants, settlements, lawsuits, birth defects, GSK
What Investors Think About SciClone Pharmaceuticals
Motley Fool
Wednesday, June 23, 2010 - 9:07am
tags:
investors, SciClone
Diabetes And Obesity Options Percolate At JNJ, Novo
Forbes
Wednesday, June 23, 2010 - 9:07am
tags:
obesity, Novo Nordisk, diabetes, JNJ, Ortho-McNeil-Janssen
Biovail and Valeant shares rise to multiyear highs
Yahoo/AP
Wednesday, June 23, 2010 - 9:05am
tags:
Biovail, M&A, Valeant Pharmaceuticals
[video] Glaxo CEO on Global Health Challenges
CNBC
Wednesday, June 23, 2010 - 9:04am
tags:
GSK, Andrew Witty, Pharma CEOs
Is the Big Pharma biotech well going to run dry?
Pharmareform
Wednesday, June 23, 2010 - 8:15am
tags:
biotech, innovation, R&D
Abbott Says It Settled Sandoz Patent Suit Over Biaxin Generic Antibiotic
Bloomberg
Wednesday, June 23, 2010 - 8:14am
tags:
Biaxin, Sandoz, Abbott Laboratories, patents, settlements, antibiotics
Johnson & Johnson CEO to go before the House
Bizjournals.com
Wednesday, June 23, 2010 - 8:10am
tags:
William Weldon, recalls, Pharma CEOs, JNJ
Abbott Laboratories: A Dividend Aristocrat on Sale
Seeking Alpha
Wednesday, June 23, 2010 - 8:09am
tags:
Abbott Laboratories, dividends
A Big Upgrade for DepoMed
Motley Fool
Wednesday, June 23, 2010 - 8:09am
tags:
Depomed

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.